Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy (TA307)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 March 2014
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer (TA118)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 1 January 2012Published: 24 January 2007
Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer (TA212)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 15 December 2010
Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer (TA100)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 April 2006
Cetuximab and panitumumab for previously untreated metastatic colorectal cancer (TA439)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 25 September 2017Published: 29 March 2017
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (TA242)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 January 2012
ColonFlag for identifying people at risk of colorectal cancer (MIB142)Product type:AdviceProgramme:Medtech innovation briefingPublished: 12 April 2018
Colonoscopic surveillance in adults with Ulcerative colitis, Crohn's disease or adenomas - Is this happening?Product type:Shared learningPublished: 2 July 2020
Colorectal cancer (NG151)Product type:GuidanceProgramme:NICE guidelineLast updated: 15 December 2021Published: 29 January 2020
Colorectal cancer (QS20)Product type:Quality standardLast updated: 1 February 2022Published: 13 August 2012
Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas (CG118)Product type:GuidanceProgramme:Clinical guidelineLast updated: 20 September 2022Published: 23 March 2011
Combined endoscopic and laparoscopic removal of colonic polyps (IPG503)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 September 2014
Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique) (IPG56)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 April 2004
Computed tomographic colonography (virtual colonoscopy) (IPG129)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 June 2005
Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer (TA668)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 6 January 2021
Endocuff Vision for assisting visualisation during colonoscopy (MTG45)Product type:GuidanceProgramme:Medical technologies guidancePublished: 7 June 2019
Endoscopic full thickness removal of non-lifting colonic polyps (IPG580)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 May 2017
Endoscopic radical inguinal lymphadenectomy (IPG398)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 June 2011
Endo-SPONGE for treating low rectal anastomotic leak (MTG63)Product type:GuidanceProgramme:Medical technologies guidancePublished: 16 December 2021
Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment (DG16)Product type:GuidanceProgramme:Diagnostics guidancePublished: 10 December 2014
GatewayC: Improving early detection of cancer through e-learning for primary careProduct type:Shared learningPublished: 31 January 2019
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer (TA61)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 May 2003
Immunoscore for predicting risk of colon cancer relapse (MIB269)Product type:AdviceProgramme:Medtech innovation briefingPublished: 3 August 2021
Intraoperative electron beam radiotherapy for locally advanced and locally recurrent colorectal cancer (IPG763)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 6 June 2023
Laparoscopic surgery for colorectal cancer (TA105)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 August 2006
Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer (IPG532)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 September 2015
Low-energy contact X-ray brachytherapy (the Papillon technique) for locally advanced rectal cancer (IPG659)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 14 August 2019
Microwave ablation for treating liver metastases (IPG553)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 April 2016
Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27)Product type:GuidanceProgramme:Diagnostics guidancePublished: 22 February 2017
Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency (TA716)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 July 2021
OSNA for colon cancer staging (MIB77)Product type:AdviceProgramme:Medtech innovation briefingPublished: 24 August 2016
Overcoming the challenges of implementing the new NICE guidance for suspected cancer: recognition and referralProduct type:Shared learningPublished: 8 January 2017
Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal) (TA240)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 29 March 2017Published: 14 December 2011
Pembrolizumab for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiency (TA914)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 20 September 2023
Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency (TA709)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 June 2021
Preoperative high dose rate brachytherapy for rectal cancer (IPG531)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 August 2015
Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care (DG56)Product type:GuidanceProgramme:Diagnostics guidancePublished: 24 August 2023
Radiofrequency ablation for colorectal liver metastases (IPG327)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 16 December 2009
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal) (TA334)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 February 2015
Regorafenib for previously treated metastatic colorectal cancer (TA866)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 8 February 2023
Selective internal radiation therapy for unresectable colorectal metastases in the liver (IPG672)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 4 March 2020
Signatera for detecting molecular residual disease from solid tumour cancers (MIB307)Product type:AdviceProgramme:Medtech innovation briefingPublished: 4 October 2022
Suspected cancer (QS124)Product type:Quality standardLast updated: 5 December 2017Published: 30 June 2016
Suspected cancer: recognition and referral (NG12)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 October 2023Published: 23 June 2015
Symptomatic Breast Referral Resource Suite: Enhancing the Suspected Cancer Recognition and Referral ProcessProduct type:Shared learningPublished: 10 November 2020
Transanal total mesorectal excision for rectal cancer (IPG713)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 15 December 2021
Trifluridine–tipiracil for previously treated metastatic colorectal cancer (TA405)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 August 2016
Virtual chromoendoscopy to assess colorectal polyps during colonoscopy (DG28)Product type:GuidanceProgramme:Diagnostics guidancePublished: 10 May 2017